NDC product
LEDERLE LEUCOVORIN
NDC 0069-5886 · Pfizer Laboratories Div Pfizer Inc
Key facts
| Product NDC | 0069-5886 |
|---|---|
| Proprietary name | LEDERLE LEUCOVORIN |
| Nonproprietary name | calcium folinate |
| Substances | LEUCOVORIN CALCIUM |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| Pharmacologic classes | Folate Analog [EPC], Folic Acid [CS] |
| Marketing start | Dec 18, 2025 |
| Marketing end | Mar 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory